Due to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Clin J Am Soc Nephrol. 2013 Nov;8(11):1907-14. doi: 10.2215/CJN.11321112. Epub 2013 Aug 29.
Diabetes mellitus is associated with increased risk of cognitive impairment. This study examines whether microvascular disease, as measured by albuminuria and decline in estimated GFR (eGFR), is associated with cognitive decline during 3.3 years of follow-up in individuals with diabetes with a normal baseline eGFR (approximately 90 ml/min per 1.73 m(2)).
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Participants were from the Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes study (N=2977; mean age 62.5 ± 5.8 years; recruitment from August 2003 to December 2005, followed through June 2009), which examined the association of intensive versus standard glucose control on cognitive function. Participants underwent three neuropsychologic tests at baseline, 20 months, and 40 months. Tests included information processing speed, verbal memory, and executive function. Mixed-effects models were used to assess the association of albuminuria and eGFR on the percentage decline in each test.
Participants with albuminuria at baseline and follow-up (persistent albuminuria) (-5.8% [95% confidence interval (CI), -7.3 to -4.2]) and participants with albuminuria at follow-up but none at baseline (progressive albuminuria) (-4.1% [95% CI, -5.6 to -2.7]) had greater percentage declines on information processing speed than participants without albuminuria at baseline and at follow-up (no albuminuria) (-2.6% [95% CI, -3.4 to -1.9]) (P=0.001 and P=0.10, respectively). There were borderline percentage changes in the test of verbal memory (4.8% [95% CI, 2.4 to 7.1] and 4.7% [95% CI, 2.5 to 7.0] versus 7.1% [95% CI, 6.0 to 8.3]; P=0.11 and P=0.08, respectively). On logistic regression analysis, persistent albuminuria (odds ratio, 1.37 [95% CI, 1.09 to 1.72]) and progressive albuminuria (odds ratio, 1.25 [95% CI, 1.02 to 1.56]) were associated with a ≥ 5% decline in information processing speed scores but not with verbal memory or executive function performance. A 1 ml/min per 1.73 m(2) per year eGFR decline had a borderline association with decline in tests of cognitive function.
Persistent albuminuria and progressive albuminuria are associated with a decline in cognitive function in relatively young individuals with diabetes with unimpaired eGFR. These findings do not rule out the possibility of other processes causing cognitive decline.
糖尿病与认知障碍风险增加有关。本研究旨在探讨微量白蛋白尿和估算肾小球滤过率(eGFR)下降(基线 eGFR 正常,约 90ml/min/1.73m²)是否与糖尿病患者 3.3 年随访期间的认知下降有关。
设计、地点、参与者和测量:参与者来自于“行动控制心血管风险在糖尿病记忆中的糖尿病研究”(N=2977;平均年龄 62.5±5.8 岁;招募时间为 2003 年 8 月至 2005 年 12 月,随访至 2009 年 6 月),该研究旨在检验强化血糖控制与标准血糖控制对认知功能的影响。参与者在基线、20 个月和 40 个月时进行了三次神经心理学测试。测试包括信息处理速度、言语记忆和执行功能。混合效应模型用于评估白蛋白尿和 eGFR 与每个测试的百分比下降之间的关系。
基线和随访时有白蛋白尿(持续性白蛋白尿)(-5.8% [95%置信区间(CI),-7.3 至-4.2])和随访时有白蛋白尿而基线时无白蛋白尿(进行性白蛋白尿)(-4.1% [95%CI,-5.6 至-2.7])的参与者在信息处理速度方面的百分比下降大于基线和随访时均无白蛋白尿的参与者(无白蛋白尿)(-2.6% [95%CI,-3.4 至-1.9])(P=0.001 和 P=0.10)。言语记忆测试的百分比变化有边缘意义(4.8% [95%CI,2.4 至 7.1] 和 4.7% [95%CI,2.5 至 7.0] 与 7.1% [95%CI,6.0 至 8.3];P=0.11 和 P=0.08)。在逻辑回归分析中,持续性白蛋白尿(比值比,1.37 [95%CI,1.09 至 1.72])和进行性白蛋白尿(比值比,1.25 [95%CI,1.02 至 1.56])与信息处理速度评分的≥5%下降相关,但与言语记忆或执行功能无关。eGFR 每年下降 1ml/min/1.73m² 与认知功能测试的下降有边缘关联。
在基线 eGFR 正常的年轻糖尿病患者中,持续性白蛋白尿和进行性白蛋白尿与认知功能下降有关。这些发现并不能排除其他导致认知下降的可能性。